Fennec Pharmaceuticals
FENC
#7871
Rank
NZ$0.73 B
Marketcap
NZ$20.96
Share price
6.61%
Change (1 day)
N/A
Change (1 year)

Earnings for Fennec Pharmaceuticals (FENC)

Earnings in 2026 (TTM): -NZ$5.29 Million

According to Fennec Pharmaceuticals's latest financial reports the company's current earnings are NZ$59.22 Million. In 2025 the company made an earning of -NZ$17.38 Million a decrease over its 2024 earnings that were of -NZ$0.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fennec Pharmaceuticals from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$5.29 Million-69.6%
2025 -NZ$17.38 Million13471.83%
2024 -NZ$0.13 Million-99.56%
2023 -NZ$28.94 Million-32.34%
2022 -NZ$42.77 Million36.71%
2021 -NZ$31.29 Million-4.21%
2020 -NZ$32.66 Million41.75%
2019 -NZ$23.04 Million29.2%
2018 -NZ$17.84 Million40.33%
2017 -NZ$12.71 Million152.64%
2016 -NZ$5.03 Million323.22%
2015 -NZ$1.19 Million-69.72%
2014 -NZ$3.93 Million-218%
2013 NZ$3.32 M-240.02%
2012 -NZ$2.38 Million-128.1%
2011 NZ$8.45 M-327.81%
2010 -NZ$3.71 Million-19.77%
2009 -NZ$4.63 Million-81.44%
2008 -NZ$24.92 Million-0.81%
2007 -NZ$25.13 Million-30.68%
2006 -NZ$36.24 Million-6.69%
2005 -NZ$38.84 Million
2003 -NZ$15.45 Million82.16%
2002 -NZ$8.48 Million9.38%
2001 -NZ$7.76 Million